Clinical Trial Update: Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ALX-0171 for Respiratory Syncytial Virus lower respiratory tract infection in Japanese children was terminated; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Lower Respiratory Tract Infection

Drugs mentioned

• ALX-0171

Snippet

Sponsor: Ablynx, a Sanofi company | Conditions: Respiratory Syncytial Virus Lower Respiratory Tract Infection | Phase 2 | Status: TERMINATED | Results posted: 2019-07-15